Peridiagnostic and cascade cancer genetic testing
نویسندگان
چکیده
منابع مشابه
Genetic testing in cancer therapeutics.
A major challenge to physicians administering drugs with a low therapeutic index, such as chemotherapeutic agents, is the variability in drug disposition and clearance. This variability accounts for the wide interpatient response to conventional doses of antineoplastic agents. Currently, most dosing regimens are based on body weight or surface area, with the decision for dose modifications typi...
متن کاملGenetic Testing for Breast and Ovarian Cancer
Genetic testing for breast and ovarian cancer has been publicly available since the mid-1990 discovery of two breast/ovarian cancer susceptibility genes named BRCA1 and BRCA2. Although many professionals say that genetic testing may be the best available preventative medicine breakthrough, controversy abounds over whether the medical benefits of BRCA1/2 mutation testing outweigh the psychologic...
متن کاملUptake of genetic testing for cancer predisposition.
Although there has been much debate about the uptake and effects of predictive testing for common cancers, such as breast and colon cancer, little has been published on the more classical tumour predisposing conditions, such as von Hippel-Lindau disease and familial adenomatous polyposis. Since 1990 the genetics departments in Manchester and Cambridge have had a genetic register for cancer pred...
متن کاملMainstreaming genetic testing of cancer predisposition genes.
Referrals are invited from consultants in secondary and/or tertiary care for patients in whom the diagnosis of EDS is suspected but not confirmed for one of the following reasons: > Diagnostic criteria according to Villefranche classification are not met > Diagnostic testing does not confirm the diagnosis suspected > Diagnostic criteria of more than one type of EDS are identified > There are si...
متن کاملGenetic and Epigenetic of Medullary Thyroid Cancer
Medullary thyroid carcinoma (MTC) is an infrequent calcitonin-producing neuroendocrine tumor that initiates from the parafollicular C cells of the thyroid gland. Several genetic and epigenetic alterations are collaterally responsible for medullary thyroid carcinogenesis. In this review article, we shed light on all the genetic and epigenetic hallmarks of MTC. From the genetic perspective, RET, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Clinical Oncology
سال: 2020
ISSN: 1759-4774,1759-4782
DOI: 10.1038/s41571-020-0348-4